A Study of Endometrial Cancer Testing With Vaginal and Endometrial Cell Samples

Overview

About this study

The purpose of this study is to collect vaginal and endometrial cell samples to study endometrial cancer.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Women at least 18 years of age.
  • Women who have had symptoms of abnormal uterine or post-menopausal bleeding, or abnormal ultrasound findings.
  • Thickened endometrial stripe.
  • Hereditary predisposition to endometrial cancer (e.g., HNPCC).
  • Women referred for endometrial biopsy to evaluate suspicion or high risk of endometrial cancer

Exclusion Criteria: 

  • Prior hysterectomy.
  • Pregnant women (there will be a verbal screen by the clinic nurse and the physician about a potential pregnancy and a pregnancy test may be conducted if there is any doubt).
  • Prior pelvic radiation. 
  • Cervical stenosis that renders Tao brush sampling impossible.

 

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Mark Sherman, M.D.

Open for enrollment

Contact information:

Shantel Williams

(904)953-9727

Williams.Shantel@mayo.edu

Rochester, Minn.

Mayo Clinic principal investigator

Jamie Bakkum-Gamez, M.D.

Contact us for the latest status

Contact information:

Cancer Center Clinical Trials Referral Office

855-776-0015

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Paul Magtibay, M.D.

Contact us for the latest status

Contact information:

Cancer Center Clinical Trials Referral Office

855-776-0015

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20492228

Mayo Clinic Footer